Table 1. Circulatory parameters of the four patients
From: Pitfalls of anesthetic management with the Impella® 5.0 device: a case series
Patient | Age (years) /sex | BSA (m2) | Primary disease | Preoperative EF (%) | Preoperative concomitant VAD | ABP PAP CVP upon arrival in the operating room (after cessation of IABP) (mmHg) | Approach vessel | Assisted flow rate (L/min-1) | CCO (L/min) and CCI (L/min/m2) monitored with pulmonary artery catheter | Postoperative concomitant VAD | Total flow rate*1 (L/min) Total flow rate/BSA (L/min/m2) | Inotropic agent and vasoconstrictor dose*2 (μg/kg/min) | Mixed venous oxygen saturation (%) | ABP PAP CVP on postoperative day 1 (mmHg) | Duration of Impella 5.0 placement (days) | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 58 M | 1.7 | ICM | 11 | PCPS IABP | 94/58 (67) 32/19 (35) 7 | RSCA | P-9 5.0 | 3.5 2.0 | None | 3.5 2.1 | DOA 6 DOB 6 NAD 0.3 | 65% | 64/59 (61) 44/26 (28) 5 | 8 | Implantable LVAD |
2 | 43 F | 1.5 | FMC | 5-10 | PCPS IABP | 71/66 (66) 28/24 (26) 8 | AsAo | P-9 4.5 | 3.1 2.1 | PCPS 2.2 L/min | 5.3 3.5 | DOA 3 DOB 6 | 86% | 86/74 (77) 19/11 (14) 10 | 17 | Implantable LVAD |
3 | 54 M | 1.8 | dHCM | 10-15 | PCPS IABP | 70/52 (63) 42/28 (31) 12 | RSCA | P-9 4.8 | 3.7 2.1 | PCPS 2.1 L/min | 5.8 3.2 | DOA 3 NAD 0.1 | 70% | 82/78 (79) 47/24 (33) 12 | 27 | Implantable LVAD |